CD4 and Herpesviridae infectious disease: Due to the risk of herpes infections, antiviral prophylactic treatment with acyclovir 200–400 mg twice daily is recommended during the course of alemtuzumab until recovery of CD4 lymphocytes to >200 cells/μl, with a minimum treatment duration of 2 months even if CD4 lymphopenia resolves earlier [99].